Follow the 광동헬스바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 광동헬스바이오 has published 8 public disclosures. The latest transaction was reported on 6 November 2025 (Other). Among the most active insiders: 에스비아이-성장사다리 코넥스 활성화펀드. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations